Biobanking 2019

September 25th - 26th, 2019 (London, UK)

With the estimated revenues of the global biobanking industry reaching US$ 27.54 billion in 2020, backed by an explosive CAGR of 9.5% between now and 2026. This market growth is fuelled by the increasing drive towards precision and personalised medicine and thus, quality biosamples are now in soaring demand.

Come join us in September 2019 and; thoroughly understand the latest developments in the biobanking industry; network with the industry experts and key opinion leaders; gain insight into how the biobanking industry at the forefront at driving precision medicine and enhancing research and discover ‘Drone4Care’, how drone delivery of biosamples can be a reality.


The event will bring together internationally recognised biorepositories, scientific pioneers from pharmaceutical companies, and academics to strengthen current knowledge in biosample management and their research applications. We will cover the most relevant hot topics including: the latest biorepository technological breakthroughs, the best practices in biobanking, shifts in the biosample regulation landscape, the international biobank societies with ESBB and ISBER, along with a whole host of successful biobanking business model structures to help reinvigorate your biobank.


Benefits of attending:

  • Discover 'Drone4care' from Laurent Dollé, the innovative and daring plan to use drones for the delivery of biomaterial. Additionally, he will be detailing the new promising technology of Tissue Microarray, a bioprocessing technology that can reduced the number of needed biosamples for research from 200 down to 1
  • Hear from UK Biobank on the continual impact of GDPR on the biobanking landscape
  • Learn about a diverse range of the most successful biobanking business models from real case studies
  • Gain insight from the global biobank collaboration societies of ESBB and ISBER, see how you can place your biobank on the international stage


Who should attend:

Head of Biobanks, Project Managers, Senior Scientists, Biobank Operations Managers, Senior Directors, Research Directors, Regulation Managers, Legal Advisors, Deputy Managers, Business Development Directors, CEO & Founders, Clinical Leads, Operating Directors, Principal Scientists, Senior R&D Managers, Principal Advisors, Heads of Marker Scouting and Sample Bank, Directors of Clinical Sample Science, Legal Counsels, Lead Scientists, Heads of Data Services & Biobanking, Executive Managers, Presidents, Medical Directors, Heads of Laboratory Services and Biobanking, Technical Coordinators, Program Directors, Heads of Laboratory Compliance, Lab Supervisors in Biosample & Repository Management Operations, Senior Directors of Human Biosample Governance, Biorepository & Program Management Global Leads

AbbVie GmbH & Co.KG; Ablynx nv; Bayer; Biostor Ireland; Bloodwise Childhood Leukaemia Cell Bank; Cambridge Blood and Stem Cell Biobank; Dublin Brain Bank ; Duke University School of Medicine; Ethical Tissue; European Sperm Bank UK Ltd.; Future Health Biobank; Gencove; GlaxoSmithKline; Health Interactive, Inc.; HRC Collaborative Centre; Human Tissue Authority; Institute Of Food Research (I F R); Instituto de Salud Carlos III; IQM; King’s College London; Kings College London; London School of Hygiene & Tropical Medicine; Medical Research Council; Modul-Bio; MRC Brain Banks Network; National Institute for Biological Standards and Control; NIBSC; NIBSC/MHRA; OpenSpecimen; Roche Products Ltd; SPD; Telethon Foundation, Tigem, Naples.; The Faroese Biobank; Topa Thermal; UCL; UCL - Queen Square Brain Bank; UCL Institute of Neurology; UK Biocentre; University of birmingham; University of Nottingham;


For more details visit:

Featured Events

P 298 Biosimilars 150x150